Eileen Maziarz, MD

Assistant Professor of Medicine
Campus mail DUMC 102359, 315 Trent Drive, Hanes House 153, Durham, NC 27710
Phone (919) 668-0789
Email address eileen.maziarz@duke.edu

Education and Training

  • Chief Resident, Medicine, Duke University School of Medicine, 2011 - 2012
  • Fellowship in Infectious Diseases, Medicine, Duke University School of Medicine, 2010 - 2011
  • Residency, Medicine, Duke University School of Medicine, 2007 - 2010
  • M.D., University of Nebraska, College of Medicine, 2007

Publications

Yarrington, Michael E., Rebekah H. Wrenn, Justin Spivey, Christopher J. Shoff, Eileen K. Maziarz, S Shaefer Spires, Nicholas A. Turner, Anthony Diez, Deverick J. Anderson, and Rebekah W. Moehring. “Well-being tradeoffs: Effect of loosening overnight restrictions on antimicrobial starts.” Infect Control Hosp Epidemiol, August 16, 2021, 1–3. https://doi.org/10.1017/ice.2021.340.

PMID
34396944
Full Text

Baker, Arthur W., Eileen K. Maziarz, Sarah S. Lewis, Jason E. Stout, Deverick J. Anderson, Peter K. Smith, Jacob N. Schroder, et al. “Invasive Mycobacterium abscessus Complex Infection After Cardiac Surgery: Epidemiology, Management, and Clinical Outcomes.” Clin Infect Dis 72, no. 7 (April 8, 2021): 1232–40. https://doi.org/10.1093/cid/ciaa215.

PMID
32133489
Full Text

Spivey, Justin, Rebekah Wrenn, Beiyu Liu, Eileen Maziarz, and Bridgette Kram. “Characterization of Isavuconazole serum concentrations after enteral feeding tube administration in a hospitalized cohort: A case series.” J Clin Pharm Ther 46, no. 2 (April 2021): 528–31. https://doi.org/10.1111/jcpt.13317.

PMID
33247433
Full Text

Ortega-Legaspi, J., A. Morris, M. Flattery, T. Alexy, A. Devore, V. Maharaj, C. Martin, et al. “Efficacy of 3 Months vs. 6 Months of Valganciclovir Prophylaxis for Heart Transplant Recipients at Intermediate Risk (R plus ) for CMV Complications.” In Journal of Heart and Lung Transplantation, 40:S116–17, 2021.

Scholars@Duke

Cole, R. T., A. Devore, A. Morris, T. Alexy, J. M. Ortega-Legaspi, M. Flattery, E. Maziarz, et al. “A Multi-Center Study of CMV Prophylaxis Strategies in Intermediate Risk (R plus ) Heart Transplant Recipients.” In Journal of Heart and Lung Transplantation, 40:S115–S115, 2021.

Scholars@Duke

Steinbrink, J. M., J. Byrns, L. Crona, M. Ellis, S. Sanoff, E. K. Maziarz, and C. R. Wolfe. “Real-World Experiences in the Transplantation of Hepatitis C Positive Kidneys.” In American Journal of Transplantation, 20:827–827, 2020.

Scholars@Duke

Saullo, J. L., A. Ferrari, E. M. Eichenberger, J. M. Steinbrink, A. W. Baker, M. Bacchus, E. K. Maziarz, et al. “Use of Letermovir for Cytomegalovirus Management in Thoracic Organ Transplantation.” In American Journal of Transplantation, 20:379–80, 2020.

Scholars@Duke

Berry, H., J. Byrns, L. Crona, T. Capes, J. M. Steinbrink, E. K. Maziarz, and C. R. Wolfe. “Pharmacy Led Initiatives for Treatment of Transplant Recipients of Hepatitis C Viremic Donors in a High Volume Transplant Center.” In American Journal of Transplantation, 20:393–393, 2020.

Scholars@Duke

Kakoullis, S. A., E. M. Eichenberger, J. M. Steinbrink, E. Maziarz, H. Ali, H. Berry, J. Haney, J. Klapper, J. M. Reynolds, and C. R. Wolfe. “Viremic Hepatitis C (HCV) Donors a Viable Option for Lung Transplant Recipients Treated with Real World Delayed Therapy.” In American Journal of Transplantation, 20:522–23, 2020.

Scholars@Duke

Melia, Michael T., Armando Paez, Gail Reid, Lisa M. Chirch, Vera P. Luther, Brian G. Blackburn, Federico Perez, et al. “The Struggling Infectious Diseases Fellow: Remediation Challenges and Opportunities.” Open Forum Infect Dis 7, no. 3 (March 2020): ofaa058. https://doi.org/10.1093/ofid/ofaa058.

PMID
32166097
Full Text

Pages